Dihydroorotate Dehydrogenase Inhibitor, Brequinar
CAS: 96201-88-6
Ref. 3D-WDA20188
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
Dihydroorotate Dehydrogenase Inhibitor, Brequinar
Synonyms:
- Brequinar sodium
- Nsc-368390
- DuP-785
- Sodium 6-Fluoro-2-(2'-Fluorobiphenyl-4-Yl)-3-Methylquinoline-4-Carboxylate
Description:
Brequinar is a dihydroorotate dehydrogenase inhibitor that has been shown to inhibit the mitochondrial function and replication of DNA. The drug is used in combination therapy with other agents, such as uridine, for the treatment of colon cancer. Brequinar works by inhibiting the formation of dihydroorotate, which is an intermediate in pyrimidine synthesis. It also has immunosuppressive properties and can be used for the treatment of autoimmune diseases.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
397.35 g/mol
Formula:
C23H14F2NNaO2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
